Everolimus Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of everolimus that may be used in the treatment of well-differentiated grade 3 neuroendocrine tumors (NETs), NETs of the gastrointestinal (GI) tract, pancreas, lung, and thymus; follicular, papillary and Hurthle cell thyroid carcinomas; thymomas and thymic carcinomas; Hodgkin lymphoma (HL); kidney cancer; perivascular epithelioid cell tumor (PEComa) and uterine sarcoma, recurrent angiomyolipoma, and lymphangioleiomyomatosis (LAM); Waldenstrom's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL); subependymal giant cell astrocytoma (SEGA); and oncocytic carcinoma.

**Synonyms:** - Afinitor Regimen - Everolimus monotherapy